WILLIAM D KERNS
Veterinary in Harvard, MA
License number
Massachusetts 5447
Issued Date
Jun 20, 2002
Expiration Date
Feb 28, 2017
Type
Veterinarian
Address
Address
Harvard, MA 01451
Professional information
Acamprosate Formulations, Methods Of Using The Same, And Combinations Comprising The Same
US Patent:
2013024, Sep 19, 2013
Filed:
May 9, 2013
Appl. No.:
13/891061
Inventors:
William D. Kerns - Harvard MA, US
Kei-Lai Fong - Berkeley CA, US
Kei-Lai Fong - Berkeley CA, US
Assignee:
Synchroneuron Inc. - Waltham MA
International Classification:
A61K 9/00, A61K 45/06
US Classification:
51421113, 514629, 5142262, 5142255, 5142258, 514327, 5142352, 51425307, 514410, 51425404, 514220, 51425941, 514469, 514438, 514321, 514326
Abstract:
Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
Acamprosate Formulations, Methods Of Using The Same, And Combinations Comprising The Same
US Patent:
2013031, Nov 21, 2013
Filed:
May 9, 2013
Appl. No.:
13/891102
Inventors:
William D. Kerns - Harvard MA, US
Kei-Lai Fong - Berkeley CA, US
Kei-Lai Fong - Berkeley CA, US
Assignee:
Synchroneuron Inc. - Waltham MA
International Classification:
A61K 31/185
US Classification:
514553
Abstract:
Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
Acamprosate Formulations, Methods Of Using The Same, And Combinations Comprising The Same
US Patent:
2013031, Nov 21, 2013
Filed:
May 9, 2013
Appl. No.:
13/891110
Inventors:
William D. Kerns - Harvard MA, US
Kei-Lai Fong - Berkeley CA, US
Kei-Lai Fong - Berkeley CA, US
Assignee:
Synchroneuron Inc. - Waltham MA
International Classification:
A61K 31/185
US Classification:
514553
Abstract:
Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
Administration Of An Anti-Endotoxin Drug By Intravenous Infusion
US Patent:
2003013, Jul 10, 2003
Filed:
Jun 13, 2002
Appl. No.:
10/171465
Inventors:
Daniel Rossignol - Mahwah NJ, US
Melvyn Lynn - East Brunswick NJ, US
William Kerns - Harvard MA, US
Melvyn Lynn - East Brunswick NJ, US
William Kerns - Harvard MA, US
International Classification:
A61K031/7016
US Classification:
514/042000
Abstract:
The invention provides methods for administering an anti-endotoxin drug, E5564, by intravenous infusion. The methods can be used for treating conditions such as endotoxemia, sepsis, and septic shock.
Method Of Treating An Individual With Methyl 1-[N6-(3-Iodobenzyl)-Adenin-9-Yl] Beta-D-Ibofuronamide
US Patent:
2005010, May 12, 2005
Filed:
Nov 12, 2003
Appl. No.:
10/705262
Inventors:
Steve Warrington - Middlesex, GB
Michael Silverman - Marblehead MA, US
William Kerns - Harvard MA, US
Pnina Fishman - Herzliya, IL
Ilan Cohn - Herzliya, IL
Michael Silverman - Marblehead MA, US
William Kerns - Harvard MA, US
Pnina Fishman - Herzliya, IL
Ilan Cohn - Herzliya, IL
Assignee:
CAN-FITE BIOPHARMA LTD. - Petach Tikva
International Classification:
A61K031/7076
US Classification:
514046000
Abstract:
A method for treating an individual with IB-MECA to achieve a therapeutic effect is provided. The method comprises administering to the individual a dose of IB-MECA in an amount and for a time such so as to achieve a maximal blood level of less than about 1.60 nM.
Acamprosate Formulations, Methods Of Using The Same, And Combinations Comprising The Same
US Patent:
2013014, Jun 6, 2013
Filed:
Jan 18, 2013
Appl. No.:
13/745619
Inventors:
William D. Kerns - Harvard MA, US
Kei-Lai Fong - Berkeley CA, US
Kei-Lai Fong - Berkeley CA, US
Assignee:
SYCHRONEURON INC. - Lexington MA
International Classification:
A61K 31/185, A61K 45/06
US Classification:
51421113, 514578, 514469, 514438, 514321, 5142255, 5142262, 51425213, 5142258, 514327, 5142352, 51425307, 514410, 51425404, 514220, 51425941
Abstract:
Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
Acamprosate Formulations, Methods Of Using The Same, And Combinations Comprising The Same
US Patent:
2013022, Aug 29, 2013
Filed:
Mar 29, 2013
Appl. No.:
13/853876
Inventors:
William D. Kerns - Harvard MA, US
Kei-Lai Fong - Berkeley CA, US
Kei-Lai Fong - Berkeley CA, US
Assignee:
Synchroneuron Inc. - Waltham MA
International Classification:
A61K 31/164
US Classification:
424457, 424484, 514629, 424468
Abstract:
Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
Use Of An Anti-Endotoxin Drug In The Prevention And Treatment Of Disease
US Patent:
2005021, Sep 29, 2005
Filed:
Dec 13, 2004
Appl. No.:
11/010550
Inventors:
Daniel Rossignol - Mahwah NJ, US
Melvyn Lynn - East Brunswick NJ, US
William Kerns - Harvard MA, US
Melvyn Lynn - East Brunswick NJ, US
William Kerns - Harvard MA, US
International Classification:
A61K031/739
US Classification:
514054000
Abstract:
The invention provides methods for preventing and treating disease involving the use of an anti-endotoxin drug.